Steps forward for cancer precision medicine
- PMID: 29170471
- DOI: 10.1038/nrd.2017.218
Steps forward for cancer precision medicine
Abstract
The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources